Home · Healthcare · AGIO
Agios Pharmaceuticals Executive Compensation
AGIO · Healthcare · FY2025 Data
Agios Pharmaceuticals is a publicly traded company in the Healthcare sector.
Total Exec Pay FY2025
$1.6M
Highest Paid Executive
$592,804
Executives Tracked
5
💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Data available:FY2025FY2024FY2023
Named Executive Officers — FY2025
ExecutiveTotal Pay
Brian Goff
Executive Officer
Sarah Gheuens M.D. Ph.D.
Executive Officer
Cecilia Jones
Executive Officer
James Burns
Executive Officer
Tsveta Milanova
Executive Officer
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Agios Pharmaceuticals discloses FY2025 compensation for 5 named executive officers, totaling $1.6M. Brian Goff, the Executive Officer, accounts for 36% of that combined total.
Brian Goff's total compensation fell 18% year-over-year, from $719,423 in FY2024 to $592,804 in FY2025.
Among 78 other Healthcare companies in this dataset, Agios Pharmaceuticals's combined tracked executive pay of $1.6M ranks in the 10th percentile (industry median: $13.6M). Its highest-paid executive, Brian Goff, ranks in the 6th percentile for top-executive pay in the sector (industry median: $6.3M).
Historical Compensation Data
Data Source: Compensation figures are sourced from Agios Pharmaceuticals's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect the most recently available fiscal year per executive. See something wrong? Report it.